Tag: betahistine

March 29, 2019

Auris Medical Announces Randomization of First Dose Cohort in AM-201 Phase 1b Proof-of-Concept Study

Auris Medical (NASDAQ:EARS) has announced the first cohort of subjects have been randomized in its Phase 1b proof-of-concpet trial of...
January 23, 2019

Auris Medical Announces Publication of New Data Highlighting the Role of Betahistine

Auris Medical (NASDAQ:EARS), a clinical-stage company dedicated to developing therapeutics that address important unmet medical needs in neurotology and central...